行情

AVDR

AVDR

Avedro
NASDAQ

实时行情|Nasdaq Last Sale

22.99
+0.11
+0.48%
已退市 16:00 11/20 EST
开盘
22.91
昨收
22.88
最高
23.04
最低
22.18
成交量
13.78万
成交额
--
52周最高
27.51
52周最低
10.75
市值
3.92亿
市盈率(TTM)
-9.8589
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AVDR 新闻

  • 日本拟向中国赠送口罩和防护服等援助物资
  • 新浪财经.2小时前
  • Facebook和雷蛇限制员工赴中国旅行
  • 新浪财经.2小时前
  • 国际油价跌至去年10月以来新低 四天下跌9%
  • 新浪财经.3小时前
  • 将救命药提价55倍的“坏小子”史克莱利面临终身禁业
  • 新浪财经.3小时前

更多

所属板块

医疗设备、用品及经销
-0.35%
医疗设备和用品
-1.02%

热门股票

名称
价格
涨跌幅

AVDR 简况

Avedro, Inc. is a commercial-stage ophthalmic medical technology company. The Company is focused on treating corneal ectatic disorders. Its Avedro Corneal Remodeling Platform is designed to stabilize and reshape the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. Its platform consists of KXL and Mosaic systems, which delivers ultraviolet A, light and a suite of single-use riboflavin drug formulations. Its KXL system is marketed to perform other corneal cross-linking procedures, such as Lasik Xtra. It offers Mosaic System for Photorefractive Intrastromal Cross-Linking (PiXL), Lasik Xtra and Accelerated Cross-Linking; KXL System for Lasik Xtra and Accelerated Cross-Linking, and Riboflavin Family for customizing each cross-linking procedures. The Company sells its products to ophthalmologists, hospitals and ambulatory surgery centers.
展开

Webull提供Avedro Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。